The information highlighted (if any) are the most recent updates for this brand.
One patient who had received 400 mg memantine orally, experienced central nervous system symptoms such as restlessness, psychosis, visual hallucinations, proconvulsiveness, somnolence, stupor, and unconsciousness. Symptomatic treatment should be initiated.